Your browser doesn't support javascript.
loading
Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility.
Douthwaite, Julie A; Brown, Christopher A; Ferdinand, John R; Sharma, Rahul; Elliott, Jane; Taylor, Molly A; Malintan, Nancy T; Duvoisin, Hannah; Hill, Thomas; Delpuech, Oona; Orton, Alexandra L; Pitt, Haidee; Kuenzi, Fred; Fish, Simon; Nicholls, David J; Cuthbert, Anna; Richards, Ian; Ratcliffe, Giles; Upadhyay, Abhishek; Marklew, Abigail; Hewitt, Craig; Ross-Thriepland, Douglas; Brankin, Christopher; Chodorge, Matthieu; Browne, Gareth; Mander, Palwinder K; DeWildt, Ruud M; Weaver, Shane; Smee, Penny A; van Kempen, Joost; Bartlett, Jon G; Allen, Paula M; Koppe, Emma L; Ashby, Charlotte A; Phipps, Julian D; Mehta, Nalini; Brierley, David J; Tew, David G; Leveridge, Melanie V; Baddeley, Stuart M; Goodfellow, Ian G; Green, Clive; Abell, Chris; Neely, Andy; Waddell, Ian; Rees, Steve; Maxwell, Patrick H; Pangalos, Menelas N; Howes, Rob; Clark, Roger.
Afiliação
  • Douthwaite JA; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. julie.douthwaite@astrazeneca.com.
  • Brown CA; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK. christopher.brown@crl.com.
  • Ferdinand JR; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.
  • Sharma R; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Elliott J; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.
  • Taylor MA; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Malintan NT; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Duvoisin H; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Hill T; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Delpuech O; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Orton AL; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.
  • Pitt H; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Kuenzi F; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Fish S; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Nicholls DJ; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.
  • Cuthbert A; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.
  • Richards I; GSK R&D Tech, Stevenage, UK.
  • Ratcliffe G; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Upadhyay A; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Marklew A; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.
  • Hewitt C; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.
  • Ross-Thriepland D; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Brankin C; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.
  • Chodorge M; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Browne G; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Mander PK; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • DeWildt RM; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Weaver S; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Smee PA; GSK R&D, Stevenage, UK.
  • van Kempen J; GSK R&D, Stevenage, UK.
  • Bartlett JG; GSK R&D Tech, Stevenage, UK.
  • Allen PM; GSK R&D Tech, Stevenage, UK.
  • Koppe EL; GSK R&D, Stevenage, UK.
  • Ashby CA; GSK R&D, Stevenage, UK.
  • Phipps JD; GSK R&D, Stevenage, UK.
  • Mehta N; GSK R&D, Stevenage, UK.
  • Brierley DJ; GSK R&D, Stevenage, UK.
  • Tew DG; GSK R&D, Stevenage, UK.
  • Leveridge MV; GSK R&D, Stevenage, UK.
  • Baddeley SM; GSK R&D, Stevenage, UK.
  • Goodfellow IG; GSK R&D, Stevenage, UK.
  • Green C; GSK R&D, Stevenage, UK.
  • Abell C; GSK R&D, Stevenage, UK.
  • Neely A; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Waddell I; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Rees S; Vice Chancellor's Office, University of Cambridge, Cambridge, UK.
  • Maxwell PH; Vice Chancellor's Office, University of Cambridge, Cambridge, UK.
  • Pangalos MN; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.
  • Howes R; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Clark R; School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Sci Rep ; 12(1): 3114, 2022 02 24.
Article em En | MEDLINE | ID: mdl-35210470
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido